Overcoming cellular multidrug resistance using classical nanomedicine formulations

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 4, 2012, Pages 421-428

  Kunjachan, Sijumon ^a   Błau, Andrzej ^b   Möckel, Diana ^a   Theek, Benjamin ^a   Kiessling, Fabian ^a   Etrych, Tomas ^c   Ulbrich, Karel ^a   Bloois, Louis Van ^d   Storm, Gert ^d   Bartosz, Grzegorz ^b   Rychlik, Błaej ^b   Lammers, Twan ^a,d  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF LODZ   (Poland)

^c INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cancer; Liposomes; Micelles; Multidrug resistance; Nanomedicine; Polymers

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DOXORUBICIN; MACROGOL 2000; POLOXAMER; POLYETHYLENEGLYCOL (2000) DISTEAROYLPHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CONFERENCE PAPER; DRUG FORMULATION; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; MICELLE; MULTIDRUG RESISTANCE; NANOMEDICINE; PRIORITY JOURNAL;

EID: 84856289716     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.08.028     Document Type: Conference Paper

References (30)

1. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
2. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Controlled Release 130 2008 98 106
3. E.V. Batrakova, S. Li, W.F. Elmquist, D.W. Miller, V.Y. Alakhov, and A.V. Kabanov Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion Br. J. Cancer 85 2001 1987 1997 (Pubitemid 34775338)
4. J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res. 47 1987 936 942 (Pubitemid 17027905)
5. P. Chytil, T. Etrych, C. KonÃk, M. SÃ-rovÃ, T. Mrkvan, J. Boucek, B. RÃ-hovÃ, and K. Ulbrich New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting J. Controlled Release 127 2008 121 130
6. C. Cuvier, L. Roblot-Treupel, J.M. Millot, G. Lizard, S. Chevillard, M. Manfait, P. Couvreur, and M.F. Poupon Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance Biochem. Pharmacol. 44 1992 509 517
7. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
8. A.C. de Verdiare, C. Dubernet, F. Nemati, E. Soma, M. Appel, J. Ferta, S. Bernard, F. Puisieux, and P. Couvreur Reversion of multidrug resistance with polyalkyl cyanoacrylate nanoparticles: towards a mechanism of action Br. J. Cancer 76 1997 198 205 (Pubitemid 27279659)
9. R. Duncan Polymer conjugates as anticancer Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 6 2006 688 701
10. T. Etrych, M. Jelinkova, B. Rihova, and K. Ulbrich New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis preliminary invitro in vivo biological properties J. Control. Release 73 2001 89 102 (Pubitemid 32406104)
11. T.. Etrych, T.. Mrkvan, P. Chytil, C. Konak, B. Rihova, and K. Ulbrich N-(2-hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin. I. New synthesis physicochemical characterization preliminary biological evaluation J. Appl. Polym. Sci. 109 2008 3050 3061
12. D. Goren, A.T. Horowitz, D. Tzemach, M. Tarshish, S. Zalipsky, and A. Gabizon Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump Clin. Cancer Res. 6 2000 1949 1957 (Pubitemid 30305094)
13. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic® block copolymers for overcoming drug resistance in cancer Adv. Drug Deliv. Rev. 54 2002 759 779 (Pubitemid 35247525)
14. T. Lammers, P. Peschke, R. Kuhnlein, V. Subr, K. Ulbrich, J.Ã. Debus, P. Huber, W. Hennink, and G. Storm Effect of radiotherapy hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems J. Control. Release 117 2007 333 341 (Pubitemid 46216581)
15. T. Lammers, V. Subr, P. Peschke, R. Kuhnlein, W.E. Hennink, K. Ulbrich, F. Kiessling, M. Heilmann, J. Debus, P.E. Huber, and G. Storm Image-guided passively tumour-targeted polymeric nanomedicines for radiochemotherapy Br. J. Cancer 99 2008 900 910
16. T. Lammers, W.E. Hennink, and G. Storm Tumour-targeted nanomedicines: principles practice Br. J. Cancer 99 2008 392 397
17. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284 (Pubitemid 30122932)
18. C. Mamot, D.C. Drummond, K. Hong, D.B. Kirpotin, and J.W. Park Liposome-based approaches to overcome anticancer drug resistance Drug Resist. 6 2003 271 279 (Pubitemid 37493783)
19. Y. Matsumura, and H. Maeda A New concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
20. L.D. Mayer, and J.A. Shabbits The role for liposomal drug delivery in molecular pharmacological strategies to overcome multidrug resistance Cancer Metastasis Rev. 20 2001 87 93 (Pubitemid 34074683)
21. T. Minko, P. Kopeckova, V. Pozharov, and J. Kopecek HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line J. Control. Release 54 1998 223 233 (Pubitemid 28342701)
22. T. Minko, P. Kopeckova, and J. Kopecek Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line J. Control. Release 59 1999 133 148 (Pubitemid 29199920)
23. F. Nemati, C. Dubernet, H. Fessi, A. Colin de VerdiÃre, M.F. Poupon, F. Puisieux, and P. Couvreur Reversion of multidrug resistance using nanoparticles in vitro: Influence of the nature of the polymer Int. J. Pharm. 138 1996 237 246 (Pubitemid 26281181)
24. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nano. 2 2007 751 760 (Pubitemid 350223348)
25. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 2010 182 195
26. V. Subr, C. Konák, R. Laga, and K. Ulbrich Coating of DNA/Poly(l-lysine) complexes by covalent Attachment of poly[N-(2-hydroxypropyl) methacrylamide] Biomacromolecules 7 2006 122 130 (Pubitemid 43154486)
27. A.R. Thierry, A. Dritschilo, and A. Rahman Effect of liposomes on P-glycoprotein function in multidrug resistant cells Biochem. Biophys. Res. Commun. 187 1992 1098 1105
28. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 2000 S81 S91
29. K. Ulbrich, and V. Subr Polymeric anticancer drugs with pH-controlled activation Adv. Drug Deliv. Rev. 56 2004 1023 1050 (Pubitemid 38520207)
30. K. Ulbrich, V. Subr, J. Strohalm, D. Plocova, M. Jelinkova, and B. Rihova Polymeric drugs based on conjugates of synthetic natural macromolecules. I. Synthesis and physico-chemical characterisation J. Control. Release 64 2000 63 79 (Pubitemid 30035308)